Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
05/1999
05/06/1999WO1999013054A3 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
05/06/1999WO1999010516A3 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
05/06/1999WO1999010504A3 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
05/06/1999WO1999009164A9 Coding sequence haplotypes of the human brca2 gene
05/06/1999WO1999007407A9 Heparin-binding growth factor (hbgf) polypeptides
05/06/1999WO1999007207A9 Hypersensitive response elicitor from pseudomonas syringae and its use
05/06/1999WO1998054301B1 Transplants for myocardial scars and method and cellular preparations therefor
05/06/1999EP0913478A2 Histidine kinase from Streptococcus pneumoniae 0100993
05/06/1999EP0913476A2 Ornithine carbamoyl transferase sequence and uses thereof
05/06/1999EP0913472A2 Human LIG-1 Homolog (HLIG-1)
05/06/1999EP0913404A1 Differentiation inhibitor
05/06/1999EP0912901A1 Method and reagent for monitoring blood levels of antiplatelet compounds
05/06/1999EP0912895A1 Method for monitoring t-cell reactivity
05/06/1999EP0912749A1 Suppression of specific classes of soybean seed protein genes
05/06/1999EP0912744A1 Recombinant dna-vector comprising genomic equine arteritis virus sequences
05/06/1999EP0912741A2 T-cell selective interleukin-4 agonists
05/06/1999EP0912740A1 Rantes homolog from prostate
05/06/1999EP0912739A2 Canine ob protein compositions and methods
05/06/1999EP0912738A2 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers
05/06/1999EP0912737A1 Human osteoclast-specific and -related dna sequences
05/06/1999EP0912735A2 Secreted proteins and polynucleotides encoding them
05/06/1999EP0912728A1 Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces
05/06/1999EP0912725A1 Glycosidase enzymes
05/06/1999EP0912724A1 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
05/06/1999EP0912723A1 Highly productive packaging lines
05/06/1999EP0912611A1 Human monoclonal antibodies to the hepatitis b surface antigen
05/06/1999EP0912608A2 Choline binding proteins for anti-pneumococcal vaccines
05/06/1999EP0912607A2 Vaccines comprising synthetic genes
05/06/1999EP0912595A1 Hodgkin's disease associated molecules and uses thereof
05/06/1999EP0912191A1 Vegetable extract, method for preparation thereof and its applications in human and veterinary medicine
05/06/1999EP0912085A1 Precise efficacy assay methods for active agents including chemotherapeutic agents
05/06/1999EP0787299A4 Receptor for a bacillus thuringiensis toxin
05/06/1999EP0667911B1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase
05/06/1999EP0624199B1 Methods for producing thrombin
05/06/1999EP0576439B1 Monoclonal antibody against lps core
05/06/1999EP0541692B1 Herpes simplex virus vp16 vaccines
05/06/1999CA2316179A1 Evaluation of changes in breast cells using nipple aspirate fluid
05/06/1999CA2307953A1 Gene therapy for stimulation of angiogenesis
05/06/1999CA2307320A1 148 human secreted proteins
05/06/1999CA2307171A1 A novel mitogenic cyclin and uses thereof
05/06/1999CA2307017A1 Erythropoietin-mediated neurogenesis
05/06/1999CA2306564A1 Serum-free, low-protein media for rotavirus vaccine production
05/06/1999CA2306183A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
05/05/1999CN1216067A Improvements in or retating to gene expression
05/05/1999CN1216064A Synthetic HIV genes
05/05/1999CN1215755A Method of introducing predetermined alteration in target sequence of genome of cell having nucleus
05/04/1999US5900476 Mutant polypeptide without cysteines, or modified to prevent disulfide bond formation suppresses binding of factor to platelets; antithrombosis agents
05/04/1999US5900375 Induction of embryogenesis using cytoskeleton inhibitors or protein synthesis inhibitors
05/04/1999US5900360 Screening protein stabilizing agents (not congo red) by incubating cell containing conformationally defective protein, determining effective concentration to improve phenotype; treatment of cystic fibrosis, scrapie
05/04/1999US5899936 Treated tissue for implantation and methods of preparation
05/04/1999CA2248171A1 Improvements in or relating to detection of salmonella
05/04/1999CA2166850C Vectors and use thereof for capturing target genes
04/1999
04/30/1999CA2248996A1 Novel ornithine carbamoyltransferase
04/29/1999WO1999020776A1 In planta method for the production of transgenic plants
04/29/1999WO1999020774A2 NOVEL MODIFIED MSP-1 NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
04/29/1999WO1999020773A2 TRANSCRIPTIONALLY-ACTIVATED AAV INVERTED TERMINAL REPEATS (ITRs) FOR USE WITH RECOMBINANT AAV VECTORS
04/29/1999WO1999020771A2 Multiply-substituted protease variants with altered net charge for use in detergents
04/29/1999WO1999020770A2 Multiply-substituted protease variants
04/29/1999WO1999020769A2 Multiply-substituted protease variants
04/29/1999WO1999020767A1 Modified vitamin k-dependent polypeptides
04/29/1999WO1999020766A2 NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
04/29/1999WO1999020765A1 MUTEINS OF INTERLEUKIN 4 SHOWING LOW-AFFINITY AND SHORT-TERM INTERACTION WITH THE COMMON η CHAIN
04/29/1999WO1999020764A1 Robo: a family of polypeptides and nucleic acids involved in nerve guidance
04/29/1999WO1999020759A1 Chemokines with amino-terminal modifications
04/29/1999WO1999020757A2 Alpha-7 nicotinic receptor
04/29/1999WO1999020756A2 Human toll homologues
04/29/1999WO1999020752A1 JMY, A CO-ACTIVATOR FOR p300/CBP, NUCLEIC ACID ENCODING JMY AND USES THEREOF
04/29/1999WO1999020747A2 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS
04/29/1999WO1999020743A1 Cell lines useful for in vitro assay for identification of carcinogens
04/29/1999WO1999020742A2 A packaging cell line producing siv-pseudotyped mlv
04/29/1999WO1999020741A1 Methods and materials for the growth of primate-derived primordial stem cells
04/29/1999WO1999020740A2 Methods and materials for the growth of primate-derived primordial stem cells
04/29/1999WO1999020738A1 Photosynthesis culture apparatus and group of photosynthesis culture apparatuses
04/29/1999WO1999020726A1 Bleaching compositions comprising multiply-substituted protease variants
04/29/1999WO1999020723A2 Multiply-substituted protease variant and amylase variant-containing cleaning compositions
04/29/1999WO1999020656A1 Anti-idiotype monoclonal antibodies, their use in active immunotherapy of malignant tumors and compositions containing them
04/29/1999WO1999020653A1 Low-toxicity human interferon-alpha analog
04/29/1999WO1999020644A1 Secreted proteins and polynucleotides encoding them
04/29/1999WO1999020643A1 Using polyamide nucleic acid oligomers to engender a biological response
04/29/1999WO1999020307A1 NOVEL pheS (BETA)
04/29/1999WO1999020298A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
04/29/1999WO1999011220A8 Transplants coated with autologous endothelial cells
04/29/1999WO1999007740A3 Lipocalin homologs
04/29/1999WO1999007735A3 Recombinant expression of insulin c-peptide
04/29/1999WO1999006066A3 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions
04/29/1999WO1999004775A9 Method of treating dopaminergic and gaba-nergic disorders
04/29/1999DE19756864C1 Production of neuronal or glial progenitor cells
04/29/1999CA2672500A1 Multiply-substituted protease variant and amylase variant-containing cleaning compositions
04/29/1999CA2672492A1 Bleaching compositions comprising multiply-substituted protease variants
04/29/1999CA2308702A1 In planta method for the production of transgenic plants
04/29/1999CA2308013A1 Human checkpoint kinase, hcds1, compositions and methods
04/29/1999CA2307330A1 Jmy, a co-activator for p300/cbp, nucleic acid encoding jmy and uses thereof
04/29/1999CA2307322A1 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
04/29/1999CA2306799A1 Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
04/29/1999CA2306796A1 Novel modified msp-1 nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
04/29/1999CA2306731A1 Using polyamide nucleic acid oligomers to engender a biological response
04/29/1999CA2306693A1 Cell lines useful for in vitro assay for identification of carcinogens
04/29/1999CA2306457A1 Secreted proteins and polynucleotides encoding them
04/29/1999CA2306251A1 Alpha-7 nicotinic receptor
04/29/1999CA2305385A1 Human toll homologues
1 ... 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 ... 1827